Using nanotechnology approaches, InnoSense can produce
ultra-sensitive biosensors offering diverse diagnostic
possibilities. Assembled in an array, these sensor chips
detect the presence of targeted biomarkers resulting in
cost-effective, fast, highly sensitive and selective
We use engineered nanomaterials on patented microelectronic
sensor chips to develop in vitro diagnostic tools for
point-of-care (POC) use. Capture molecules attached to our
sensor devices specifically-detect biomarkers from biofluids
such as blood, saliva, cerebrospinal fluid (CSF), and urine.
The scalable sensor array can generate results within 30
minutes at femtomolar sensitivity with microliters of sample.
Leveraging from our deep-learning AI platform, we
continuously improve accuracy to intelligently-identify